CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) announced today that Paul Clancy has been appointed Executive Vice President and Chief Financial Officer, effective August 13, 2007. He reports directly to James C. Mullen, the company’s Chief Executive Officer.
